-
21
-
22
Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia
Published 2024-09-01Subjects: “…hematologic malignancies…”
Get full text
Article -
23
The Effects of High Particulate Matter Levels on Platelet Recovery in Patients Receiving Prophylactic Platelet Transfusion
Published 2025-02-01Subjects: Get full text
Article -
24
A New Challenging Strategy in the Prevention and Management of Tumor Lysis Syndrome in Patients with Chemo-Sensitive Hematological Malignancies
Published 2019-01-01“…It happens frequently in cancers receiving chemotherapy, particularly hematological malignancies. It can lead to death in severe cases. …”
Get full text
Article -
25
-
26
Knowledge on the Use of Biosimilars in Hematological Malignancies Amongst Health Care Workers at a Tertiary Hospital in Northeast Nigeria
Published 2024-07-01Subjects: Get full text
Article -
27
Optimal Molecular Methods in Detecting p190BCR-ABL Fusion Variants in Hematologic Malignancies: A Case Report and Review of the Literature
Published 2015-01-01“…Patients with BCR-ABL1 positive hematologic malignancies and Philadelphia-like B-lymphoblastic leukemia (B-ALL) are potential candidates for targeted therapy with tyrosine kinase inhibitors (TKI). …”
Get full text
Article -
28
-
29
-
30
Emergency Combination of Four Drugs for Bloodstream Infection Caused by Carbapenem-Resistant Enterobacteriaceae in Severe Agranulocytosis Patients with Hematologic Malignancies after Hematopoietic Stem Cell Transplantation
Published 2020-01-01“…In this study, four agranulocytosis patients with hematologic malignancies after HSCT receiving treatment for carbapenem-resistant Enterobacteriaceae- (CRE-) BSI were included. …”
Get full text
Article -
31
-
32
-
33
One Year Duration of Immune Response Following a 3rd Booster Dose of mRNA Vaccine Against COVID‐19 in 292 Patients With Hematological Malignancies in University Hospital Ostrava, Czech Republic
Published 2024-12-01“…Materials and Methods We have vaccinated 292 patients with all hematological malignancies with a third dose of mRNA COMIRNATY vaccine with a 12‐month follow‐up period in our center in Ostrava, Czech Republic. …”
Get full text
Article -
34
Synthesis and Anti-Cancer Activity In Vitro of Synephrine Derivatives
Published 2024-12-01Subjects: Get full text
Article -
35
Editorial: Two decades of targeted therapies in hematology: new targets and novel combinations
Published 2025-01-01Subjects: Get full text
Article -
36
CRISPR-Cas9 in basic and translational aspects of cancer therapy
Published 2024-11-01Subjects: Get full text
Article -
37
Critically ill adult patients with acute leukemia: a systematic review and meta-analysis
Published 2025-01-01Subjects: Get full text
Article -
38
Pharmacological activity of OST-01, a natural product from baccharis coridifolia, on breast cancer cells
Published 2025-02-01Get full text
Article -
39
A Rare Case of Immunotactoid Glomerulopathy Associated with Hodgkin Lymphoma
Published 2021-01-01“…In hematologic malignancies, multiple myeloma and other mature B-cell malignancies are the most common hematologic malignancies, and Hodgkin lymphoma (HL) is extremely rare. …”
Get full text
Article -
40